<!DOCTYPE html>
<html>
<head>
<title>Reference for Hepatitis B Virus</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<link href="../Abiyotek.css" type="text/css" rel="stylesheet">
<script type="text/javascript" src="/include/bigimage.js"></script>
<script type="text/javascript" src="/include/css.js"></script>
<script type="text/javascript" src="/include/dom-xml.js"></script>
<script type="text/javascript" src="/include/colorContrasting.js"></script>
<script type="text/javascript" src="/include/htmlTOCgenerator.js"></script>
<script type="text/javascript" src="/include/logos.js"></script>
<script type="text/javascript" src="../AbiyotekDocs.js"></script>
<style type="text/css">
  .features-td {font-size:80%;}
  td ul {margin-top:0;}
</style>
</head>
<body onload="//initAbiyotekDoc();">
<p style="float:left;width:10%;margin:0 auto auto 0;">
<a href="."><img src="../images/AbiyotekLogo.png"
 alt="company logo"></a>

<p id="title">
Hepatitis B Virus<br>HBV

<p id="subtitle">
A Reference

<div class="outerblock">

<p>
Content created for Ankara Biyoteknoloji Ara&#351;t&#305;rma San ve Tic Ltd &#350;ti.
<hr>
<p>
Project pages for the cloning and expression of recombinant proteins for HBV can be
accessed from the links below:
<ul>
<li><a href="HBsAgCloning.html">Hepatitis B Virus Surface Antigen (HBsAg)</a>
<li><a href="HBcAgCloning.html">Hepatitis B Virus Core Antigen (HBcAg)</a>
</ul>

<hr>

<p>
See also a <a href="/presentations/Hepatitis B Virus.pptx">PowerPoint presentation on HBV</a>

<hr>

<h1>Genomics</h1>
Hepatropic virus genomes reported to NCBI Genome database are listed in table

</div> <!-- class=outerblock -->

<table class="widetable td-center">
<tr><th>Host/Target Organism
 <th>Source
 <th>Family/Genus
 <th>Length/Size (bp)
 <th style="width:8em;">Entry date
 <th>Other/Comments
<tr><td class="left"><a 
href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=genome&amp;Cmd=ShowDetailView&amp;TermToSearch=16449">
  primates (human)</a>
 <td>human plasma
 <td>Orthohepadnaviridae/
 Orthohepadnavirus
 <td>3215 nt
 <td>7 June 1987
 <td class="left">genome is serotype <i>ayr</i>;
 compared to three other subtypes
<tr><td class="left"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=genome&amp;Cmd=ShowDetailView&amp;TermToSearch=10039">
     duck</a>
 <td>
 <td>Avihepadnaviridae/
 <td>3027 nt
 <td>11 Nov 1992
 <td class="left">
<tr><td class="left"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=genome&amp;Cmd=ShowDetailView&amp;TermToSearch=10235">
   ground squirrel</a>
 <td>
 <td>Orthohepadnaviridae/
 Orthohepadnavirus
 <td>3311 nt
 <td>2 Aug 1993
 <td class="left">linear DNA
<tr><td class="left"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=genome&amp;Cmd=ShowDetailView&amp;TermToSearch=10242">
    heron</a>
 <td>
 <td>Avihepadnaviridae/
 <td>3027 nt
 <td>2 Aug 1993
 <td class="left">
<tr><td class="left"><a href="">Sheldgoose</a>
 <td>
 <td>Avihepadnaviridae/
 <td>3051 nt
 <td>14 June 2004
 <td class="left">
<tr><td class="left"><a href="">Ross's goose</a>
 <td>
 <td>Avihepadnaviridae/
 <td>3018 nt
 <td>14 June 2004
 <td class="left">
<tr><td class="left"><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=genome&amp;Cmd=ShowDetailView&amp;TermToSearch=17761">snow goose</a>
 <td>
 <td>Avihepadnaviridae/
 <td>3024 nt
 <td>25 June 2004
 <td class="left">
</table>

<div class="outerblock">

<h1>Human HBV</h1>
<p>
Genome sequences at NCBI:
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/nuccore/21326584"><i>ayr</i> genome</a>
<br>3215 bp; 4 genes, 7 proteins
<li><a href="http://www.ncbi.nlm.nih.gov/nuccore/U95551.1"><i>ayw</i> genome</a>
<br>3182 bp; 4 orf sequences (polymerase, surface antigen, x-protein, core precsuror); from HBV-producing human hepatoblastoma cell line
<li><a href="http://www.ncbi.nlm.nih.gov/nuccore/GU357846.1"><i></i> genome</a>
<br>isolate Y10 (China) 3182 bp; 4 genes, 7 proteins, 
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20174575">PubMed ref</a>
</ul>
<p>
For these circular chromosomes, in most case nt 1 is a <i>Eco</i>RI restriction
site cut point.

</div>


<table class="widetable">
<tr><th colspan="5">Gene
  <th colspan="4">Gene Product
<tr>
<!-- Genes columns -->
 <th>Name
 <th>Other Name(s)
 <th>Genome Position: Start-End
 <th>Elements Type: Name
 <th>Elements Positions
<!-- Gene Product columns -->
 <th>Gene Product Type: Name
 <th>Gene Product Function
 <th>Translation Length: Start-End
 <th>Domains/Features
<!-- data -->
<tr><td>
   <a href="http://www.ncbi.nlm.nih.gov/gene/944565">
   HBVgp1 
   </a>
 <td>polymerase
 <td>2307&rarr;3215|1&rarr;1623
 <td>
 <td>
 <td>protein:  <a href="http://www.ncbi.nlm.nih.gov/protein/NP_647604.2">
    polymerase</a>
 <td>RNA-dependent DNA polymerase (reverse transcriptase)
 <td>843 aa (94463 Da)<br>genome: 2307&rarr;3215|1&rarr;1623
 <td class="features-td"><ul>
  <li>aa 1-352:
    <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=143993">
		conserved domain PFAM 00242</a>: DNA polymerase (viral) N-terminal domain
  <li>aa 381-600: 
    <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=143860">
		conserved domain PFAM 00078</a>: Reverse transcriptase (RNA-dependent DNA polymerase)
  <li>aa 515-600:
    <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=143860">
		conserved domain cI02808</a>: RT-like Superfamily
  <li>aa 517, 518, 549, 551, 552, 596, 597:
    <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=73150">
		conserved domain cd00304</a>: active site residues (RT-like)
  <li>aa 518:
    <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=73150">
		conserved domain cd00304</a>: nucleotide-binding site
  <li>aa 601-843:
    <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=144068">
		conserved domain PFAM 00336</a>: DNA polymerase (viral) C-terminal domain
  </ul>
<tr><td rowspan="3">
   <a href="http://www.ncbi.nlm.nih.gov/gene/944569">
   HBVgp2
   </a>
 <td rowspan="3">pre-S1/pre-S2/S
 <td rowspan="3">2848&rarr;3215|1&rarr;835
 <td rowspan="3">
 <td rowspan="3">
 <td>protein:  <a href="http://www.ncbi.nlm.nih.gov/protein/NP_647605.1">
   S&nbsp;protein
  </a>
 <td>major envelope protein
 <td>226 aa (25248 Da)<br>genome: 155&rarr;835
 <td class="features-td">
   <ul><li>aa 1-208: 
      <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=109739">
       conserved domain PFAM 00695</a>: 
       Hepadnavirus major surface antigen (vMSA)
    </ul>
  <tr>
   <td>protein:  <a href="http://www.ncbi.nlm.nih.gov/protein/YP_355334.1">
   			M&nbsp;protein
     </a><br>(middle S protein)<br>pre-S2/S
   <td>envelope protein
   <td>281 aa (31021 Da)<br>genome: 3205&rarr;3215|1&rarr;835
   <td class="features-td"><ul>
     <li>aa 1-263:
       <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=109739">
       conserved domain PFAM 00695</a>: 
       Hepadnavirus major surface antigen (vMSA)
     </ul>
  <tr>
   <td>protein:  <a href="http://www.ncbi.nlm.nih.gov/protein/YP_355333.1">
   			L&nbsp;protein
     </a><br>(large S protein)<br>pre-S1/pre-S2/S
   <td>envelope protein (receptor binding)
   <td>400 aa (43538 Da)<br>genome: 2848&rarr;3215|1&rarr;835
   <td class="features-td"><ul>
     <li>aa 30-382:
       <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=109739">
       conserved domain PFAM 00695</a>: 
       Hepadnavirus major surface antigen (vMSA)
     </ul>
<tr><td>
   <a href="http://www.ncbi.nlm.nih.gov/gene/944566">
   HBVgp3
   </a>
 <td>X
 <td>1374&rarr;1838
 <td>
 <td>
 <td>protein:  <a href="http://www.ncbi.nlm.nih.gov/protein/NP_647606.1">
   X&nbsp;protein
   </a>
 <td>unknown, required for viral replication
 <td>154 aa (16378 Da)<br>genome: 1374-1838
   <td class="features-td"><ul>
     <li>aa 1-142:
       <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=109783">
       conserved domain PFAM 00739</a>: 
       Trans-activation protein X
     </ul>
<tr><td rowspan="2">
   <a href="http://www.ncbi.nlm.nih.gov/gene/944568">
   HBVgp4
   </a>
 <td rowspan="2">precore/core
 <td rowspan="2">1814&rarr;2452
 <td rowspan="2">
 <td rowspan="2">
 <td>protein:  <a href="http://www.ncbi.nlm.nih.gov/protein/NP_647607.1">
    Core and e antigen</a>
 <td>major core (nucleocapsid) protein
 <td>183 aa (20964 Da)<br>genome: 1901&rarr;2452
 <td class="features-td">
   <ul><li>aa 2-149: 
      <a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=109943">
       conserved domain PFAM 00906</a>: 
       Hepatitis core antigen:  DNA-binding Arg-rich C-terminal
    </ul>
   <tr>
   <td>protein: <a href="http://www.ncbi.nlm.nih.gov/protein/YP_355335.1">
     precore/core</a>
   <td>major core (nucleocapsid) protein
   <td>212 aa (24158 Da)<br>genome: 1814&rarr;2452
   <td>
</table>


<table class="td-center widetable" style="margin:auto 2em;">
<caption>Genotype Classification</caption>
<tr><th>Genotype  <th>Subgenotypes   <th>Distribution   
    <th style="width:14em;">Reference Standards <br><small>(Accession Number)</small>
    <th style="width:18em;">Publication Reference
    <th>Serological Subtypes
<tr><td>A         <td>2              <td>northwest Europe, North America, Africa
   <td><a href="http://www.ncbi.nlm.nih.gov/nuccore/X02763">X02763</a> (A)  <br>
      <a href="http://www.ncbi.nlm.nih.gov/nuccore/AF297621">AF297621</a> (A<sub>afr</sub>)
   <td><small>
     <br><a href="http://www.ncbi.nlm.nih.gov/pubmed/11596083">Owiredu et al. (2001)</a></small>
   <td><i>adw2</i>, <i>ayw1</i>
<tr><td>B         <td>4              <td>southeast Asia
   <td><a href="http://www.ncbi.nlm.nih.gov/nuccore/D00330">D00330</a> (B<sub>a</sub>)  <br>
      <a href="http://www.ncbi.nlm.nih.gov/nuccore/AB073858">AB073858</a> (B<sub>j</sub>)
   <td><small><a href="http://www.ncbi.nlm.nih.gov/pubmed/3171552">Okamoto et al (1988)</a>
     <br><a href="http://www.ncbi.nlm.nih.gov/pubmed/12021331">Sugauchi et al (2002)</a></small>
   <td><i>adw2</i>, <i>ayw1</i>
<tr><td>C         <td>4              <td>southeast Asia
   <td><a href="http://www.ncbi.nlm.nih.gov/nuccore/AB033556">AB033556</a> (C)  <br>
      <a href="http://www.ncbi.nlm.nih.gov/nuccore/AB048704">AB048704</a> (C<sub>aus</sub>)
   <td><small><a href="http://www.ncbi.nlm.nih.gov/pubmed/3171552">Okamoto et al (1988)</a>
     <br><a href="http://www.ncbi.nlm.nih.gov/pubmed/11257194">Sugauchi et al (2001)</a></small>
   <td><i>adw2</i>, <i>adrq+</i>, <i>adrq&minus;</i>, <i>ayr</i>, <i>adr</i>
<tr><td>D         <td>4              <td>Mediterranean basin, Near East (most common)
   <td><a href="http://www.ncbi.nlm.nih.gov/nuccore/X02496">X02496</a>
   <td><small><a href="http://www.ncbi.nlm.nih.gov/pubmed/3996597">Bichko et al (1985)</a></small>
   <td><i>ayw2</i>, <i>ayw3</i>, <i>ayw4</i>
<tr><td>E         <td>               <td>east Africa
   <td><a href="http://www.ncbi.nlm.nih.gov/nuccore/X75657">X75657</a>
   <td><small><a href="http://www.ncbi.nlm.nih.gov/pubmed/8291231">Norder et al (1994)</a></small>
   <td><i>ayw4</i>
<tr><td>F         <td>2              <td>western hemisphere
   <td><a href="http://www.ncbi.nlm.nih.gov/nuccore/X69798">X69798</a>
   <td><small><a href="http://www.ncbi.nlm.nih.gov/pubmed/8345355">Naumann et al (1993)</a></small>
   <td><i>adw2</i>, <i>ayw4</i>, <i>adw4q&minus;</i>
<tr><td>G         <td>               <td>a few individuals in France, USA, Germany
   <td><a href="http://www.ncbi.nlm.nih.gov/nuccore/AF160501">AF160501</a>
   <td><small><a href="http://www.ncbi.nlm.nih.gov/pubmed/10640543">Stuyver et al (2000)</a></small>
   <td><i>adw2</i>
<tr><td>H         <td>               <td>central America (Amerindians)
   <td><a href="http://www.ncbi.nlm.nih.gov/nuccore/AY090454">AY090454</a>
   <td><small><a href="http://www.ncbi.nlm.nih.gov/pubmed/12124470">Arauz-Ruiz et al (2002)</a></small>
   <td><i>adw4</i>
</table>

<div class="outerblock">


<table>
<caption>Primers used in the amplification and sequencing of HBV envelope/polymerase
region</caption>
<tr><th>Primer name <th>Primer location<sup><i>a</i></sup>
  <th>Primer location<sup><i>b</i></sup>  <th>Primer sequence
<tr><td>OS1  <td>nt 1408ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“1430 <td>2808ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“2830 <td>5&prime;GCCTCATTTTGTGGGTCACCATA-3&prime;
<tr><td>OS2  <td>nt 2798ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“2817 <td>977ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“996   <td>5&prime;-TCTCTGACATACTTTCCAAT-3&prime;
<tr><td>JM   <td>nt 1676ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“1696 <td>3076ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“3096 <td>5&prime;-TTGGGGTGGAGCCCTCAGGCT-3&prime;
<tr><td>TTA3 <td>nt 2128ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“2145 <td>307ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“325   <td>5&prime;-AAATTCGCAGTCCCCAAC-3&prime;
<tr><td>Seq2 <td>nt 2121ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“2139 <td>300ÃƒÂ¢Ã¢â€šÂ¬Ã¢â‚¬Å“318   <td>5&prime;-TTGGCCAAAATTCGCAGTC-3&prime;
<tr><td colspan="4" style="font-size:75%;">
<sup><i>a</i></sup> Numbering according to HPBADR1CG
<br> <sup><i>b</i></sup> Numbering according to <i>Eco</i>RI site
<br> From Table 5 of Bartholomeusz A, Schaefer S (2004) <i>Rev. Med. Virol.</i> 
<b>14</b>, 3-16. 
</table>


<h1>Biology and Life Cycle</h1>
<p>
HBV is a double-stranded DNA virus with partial single-stranded nature.
The virion specifically infects hepatocytes of the animal liver.  Viruses
specific for and infecting the liver of several mammalian and avian species 
have been identified and characterized.
<p>

<h1>Genome and Protein Structure</h1>

<h2>Surface Antigen (HBsAg)</h2>
<p>
The virus synthesizes three forms of the surface antigen.  All the three forms
have a C-terminal portion in common.  The S (short form) is 226 amino acids.
The M (pre-S2) form contains a longer N-terminal extension of 55 amino acids and
then the 226 amino acids that are the S form, a total of 281 amino acids.
The L (pre-S1) form contains the M sequence plus either 109 or 118 additional
amino acids to the N-terminus, a total of either 390 or 399 amino acids.  The
difference in length of L is dependent on which of the current eight genotypes
the virus is.
<p>

The core translated S sequence is quite hydrophobic and likely the part of the
surface antigen that anchors to the host plasma membrane that envelopes the
viral protein coat.  The S protein structure shows hydrophobic region (putative
transmembrane segment) and two hydrophilic regions.  The surface exposed region
is probably between amino acids 99-168.  

Virions can be composed of S proteins exclusively and the 
viral particles look the same as those which have mixes of M and L proteins.

<p>
The pre-S domains in M and L are hydrophilic and likely lie outside the envelope
membrane.  They contain glycosylation sites.  In addition, the L protein N-terminus
is myristylated.  The pre-S domain may very likely be involved in the infection
process, and they contain antigenic sites reactive to B and T lymphocytes. 
The pre-S domain bind to hepatocytes and polymerized human serum albumin.


<h2>Serological Types</h2>
<p>
Before the molecular structure (DNA and protein sequences) were understood, 
different HBV types were distinguished serologically.  Immunochemical methods
included passive hemagglutination (pHA) and radioimmunoassay (RIA).  After ELISA
was introduced in 1971, an ELISA-based assay was reported by Wolters et al 
(1976).  Two types were known in 1977 (<i>ad</i> and <i>ay</i>).  Tanaka et al
introduced the Hepanostika test kit in 1980.

<p>
Okamoto et al (1988) attempted to define the serological subtypes at the 
nucleotide sequence level, with sequence variations of 2-8%.
Norder et al (1992) identified the amino acids responsible for the serological
subtype variation:
<ul>
<li><b>d|y</b> determinant is because of allelic variation in amino acid
position 122
<li><b>r|w</b> determinant is because of allelic variation in amino acid
position 160
</ul>
<p>
The variation is because of Lys&rarr;Arg sequence transitions.
<p>
Differences between <i>ayw1</i> and <i>ayw2</i> were at five amino acid positions:
F134Y, T143S, A159G, Y161F, V168A;  the <i>ayw1</i> and <i>adw2</i> did not 
differ in these five positions however, but they did differ as follows T114S,
K122R, N131T.  The <i>w1</i> subtype requires R122.  The <i>w3</i> subtype
requires a T127.  The <i>w4</i> subtype requires L127 and S140.  Note that in
other types, the 127 position is Pro, so a transition to either Leu or Thr 
is a significant structural change.

<p>
<img src="HBV-viral-subviral-particles.png"
 alt="HBV viral and subviral particles">
<p>
The figure above shows a schematic structure of the HBV particle and subviral 
particles. HBV is an enveloped virus with a diameter of about 42 nm (42 nm 
particle). The envelope is formed by the three viral surface proteins LHBs, MHBs 
and SHBs that surround the viral nucleocapsid. The core protein (HBcAg) forms 
the nucleocapsid that harbors the partially double-stranded circular DNA genome 
that is covalently linked to the viral polymerase. In the serum of HBV-positive 
patients, large amounts of non-infectious subviral particles in the form of 
filaments or spheres (20nm particles) are found; these are composed of the viral 
surface proteins, but lack the viral nucleic acid.
</div>

<p style="text-align:center;">
<img src="HBV-virion-formation.png"
 alt="Formation of the HBV virion in the ER">

<div class="outerblock">
<p>
The figure above shows schematically the structure of the HBV surface proteins. 
The S-domain is common to all three HBV surface proteins. In the case of the 
large surface protein (LHBs), TM1 is not used as a start transfer signal, 
resulting in a cytoplasmic orientation of the PreS1PreS2 region. In a fraction 
of LHBs the PreSPreS2 domain is posttranslationally translocated across the ER 
membrane. In this case, the PreS1PreS2 domain faces the lumen of the ER. The two 
forms of LHBs fulfill different functions. This fraction that faces the ER lumen 
is exposed to the viral surface in the mature viral particle and is involved in 
the attachment process. The cytoplasmic form mediates the contact to the 
nucleocapsid and triggers intracellular signal transduction cascades by the 
interaction of the PreS2 domain with protein kinase C (PKC).

<p class="center">
<img src="HBV-packaging-maturation.png"
 alt="Genome packaging and nucleocapsid maturation">
<p>

The figure above shows genome packaging and nucleocapsid maturation. HBV 
nucleocapsid formation starts when the complex of the RNA pregenome, HBV 
polymerase and HBcAg dimers has formed. Efficient packaging of the RNA pregenome 
requires phosphorylation in the C-terminal part of the core protein. Conversion 
of the immature RNA-containing nucleocapsid to the mature DNA-containing 
nucleocapsid is associated with dephosphorylation and conformational changes. 
These significant differences in the structure between the RNA-containing 
immature nucleocapsid and the mature nucleocapsid trigger the envelopment of the 
mature nucleocapsid.


</div> <!-- class="outerblock" -->


</body>
</html>
